taurocholic acid has been researched along with am 251 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egawa, S; Fukuyama, S; Maruyama, I; Matsuda, K; Matsuno, S; Mikami, Y; Sunamura, M; Takeda, K | 1 |
1 other study(ies) available for taurocholic acid and am 251
| Article | Year |
|---|---|
The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis.
Topics: Acute Disease; Animals; Arachidonic Acids; Blood Pressure; Disease Models, Animal; Endocannabinoids; Fluorescent Antibody Technique, Indirect; Immunohistochemistry; Male; Pancreatitis, Acute Necrotizing; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Random Allocation; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Survival Rate; Taurocholic Acid; Time Factors | 2005 |